Journal of International Reproductive Health/Family Planning ›› 2023, Vol. 42 ›› Issue (4): 310-316.doi: 10.12280/gjszjk.20230089

• Review • Previous Articles     Next Articles

Regulatory Role of N6-Methyladenosine Modification in Oogenesis and Early Embryonic Development

WEN Xin, ZHAO Xiao-li, LUAN Zu-qian, GAO Na, DONG Rong, XIA Tian()   

  1. First Teaching Hospital of Tianjin University of Tranditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300193, China
  • Received:2023-02-27 Published:2023-07-15 Online:2023-07-26
  • Contact: XIA Tian E-mail:xiatian76@163.com

Abstract:

N6-methyladenosine (m6A) refers to the methylation modification at the N6 position of adenosine in RNA, which is the most abundant epitranscriptomic modification in mammalian mRNA. m6A depends on the co-regulatory effects of methyltransferase (Writer), demethylase (Eraser) and m6A binding protein (Reader). Numerous studies have shown that m6A and its regulatory enzymes are present in the follicles and early embryonic tissues at all development stages, and that m6A is extensively involved in the mRNA metabolic processes by virtue of their dynamic, reversible and sensitive properties. Therefore, m6A participates in the regulation of oogenesis, nuclear reprogramming, lineage differentiation, implantation, and gestation maintenance of early embryos at the post-transcriptional level. Because m6A is largely related to female fertility and pregnancy outcome, m6A may be a new marker of diagnosis and prognosis of many reproductive diseases, or a potential therapeutic target.

Key words: RNA, messenger, Oogenesis, Embryonic development, Methylation